1
项与 阿替普酶生物类似药(Generium) 相关的临床试验A Multi-center, Randomized, Single-blind, Parallel Group Clinical Trial to Evaluate the Efficacy and Safety of the Revelise® (GENERIUM, Russia) as Compared With the Actilyse® (Boehringer Ingelheim Pharma GmbH and Co.KG, Germany) in Patients With Acute Myocardial Infarction With ST-segment Elevation on ECG
Thi is is a multi-center, randomized, single-blind, parallel group clinical trial to evaluate the efficacy and safety of the intravenious thrombolysis with Revelise® (GENERIUM, Russia) in comparosin with the Actilyse® (Boehringer Ingelheim Pharma GmbH and Co.KG, Germany) in patients with acute myocardial infarction (MI) with ST-segment elevation on the electrocardiogram (ECG). The thrombolisis was performed within the period of up to 6 hours and from 6 to 12 hours from the MI symptoms onset.
100 项与 阿替普酶生物类似药(Generium) 相关的临床结果
100 项与 阿替普酶生物类似药(Generium) 相关的转化医学
100 项与 阿替普酶生物类似药(Generium) 相关的专利(医药)
100 项与 阿替普酶生物类似药(Generium) 相关的药物交易